Kevin Soucy , Ph.D.
Assistant Professor, Departments of Cardiovascular & Thoracic Surgery and Bioengineering
Kevin G. Soucy, Ph.D., is an Assistant Professor in the departments of Cardiovascular & Thoracic Surgery and Bioengineering. Dr. Kevin Soucy earned his Bachelor’s degree in Mechanical Engineering from the University of New Hampshire in 2003. He then studied Biomedical Engineering at Johns Hopkins University, receiving his Master’s degree in 2005 and his Ph.D. in 2010. His graduate research studied the effects of aging and ionizing radiation on the vasculature, as well as potential biologic countermeasures against vascular radiation injury. Upon completion of his graduate degrees, he joined the Bioengineering department at the University of Louisville as a Postdoctoral Associate, working with the Advanced Heart Failure Research group at the Cardiovascular Innovation Institute (CII). Since joining the CII, Dr. Soucy has published 11 peer-reviewed journal articles has been involved in research funded through NIH-SBIR, KSTC, American Heart Association, and industry contracts totaling over $6.5 million. He is a member of prestigious organizations, such as the American Society of Artificial Internal Organs and Biomedical Engineering Society. Dr. Soucy is currently the Roger M. Prizant Research Fellow and became full-time faculty at UofL in 2013.
Dr. Soucy’s broad research interests are the functional and molecular alterations of the heart and vasculature in cardiovascular disease, particularly heart failure, and to study how mechanical circulatory support devices (MCSD) can be more effectively used to improve these conditions. Dr. Soucy has expertise in vascular biology, oxidative stress and mechanotransduction pathways, small and large animal models, and hemodynamic data acquisition and analysis. Dr. Soucy is currently working on the development of MCSD, with a focus on optimizing MCSD flow profiles for heart failure patients and investigating the impact of MCSD-generated flow on the vasculature. He has studied flow modulation of continuous flow left ventricular assist devices (LVAD) as a strategy for generating more-physiologic pulsatile flow with LVAD support. He has worked on the development of novel cardiovascular devices for left ventricular access, aortic valve bypass, and atrial appendage occlusion. Dr. Soucy also has an interest in novel therapeutic strategies for myocardial recovery of heart failure patients. He is involved in testing synergistic treatment options of MCSD and biological scaffolding materials to potentially promote myocardial remodeling and recovery.